0.4501
2.78%
0.0041
Aditxt Inc Borsa (ADTX) Ultime notizie
ADMA Biologics Stock Soars 76.2% in 3 Months: Right Time to Invest? - Yahoo Finance
Raymond James lifts Adma Biologics Inc [ADMA] price estimate. Who else is bullish? - The DBT News
Addentax Group Corp. (NASDAQ:ATXG) Short Interest Down 17.9% in August - Defense World
Keeping an Eye on Adma Biologics Inc (ADMA) After Insider Trading Activity - Knox Daily
AdaptHealth Stock Earns RS Rating Upgrade - MSN
Adma Biologics Inc (NASDAQ:ADMA) stock crossing the finish line today - US Post News
Analog Devices, Inc. (NASDAQ:ADI): A Chip Stock Powering The AI Boom - Insider Monkey
Analytical Overview: Adma Biologics Inc (ADMA)’s Ratios Tell a Financial Story - The Dwinnex
DekaBank Deutsche Girozentrale Sells 6,400 Shares of Amdocs Limited (NASDAQ:DOX) - Defense World
Analog Devices is Citi's new top semiconductor pick - Investing.com
Digital Health Acquisition (NASDAQ:DHAC) Trading Down 2.5% - Defense World
Automatic Data Processing Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Adma Biologics Inc (ADMA) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Adma Biologics Inc (ADMA) Performance and Fundamentals Dashboard tells a completely different story - SETE News
Predicting Adaptimmune Therapeutics Plc ADR’s (ADAP) earnings for the current quarter - US Post News
DEADLINE ALERT for ABR, FIVE, DXC, and INDV: The Law - GlobeNewswire
In the Green: Aditxt Inc (ADTX) Closes at 0.45, Up/Down -10.00 from Previous Day - The Dwinnex
A Closer Look at Aditxt Inc (ADTX) Stock Gains - The InvestChronicle
Q2 2026 EPS Estimates for Analog Devices, Inc. Decreased by Analyst (NASDAQ:ADI) - MarketBeat
Adobe Shares Decline Amid AI Software Concerns - Invezz
AvidXchange Holdings Inc. (AVDX): Best New Tech Stock To Buy Now - Insider Monkey
Adtran Holdings Inc. (ADTN): Best Emerging Tech Stock to Buy Now - Insider Monkey
Automatic Data Processing Inc. stock rises Friday, still underperforms market - MarketWatch
ADMA Shares Experience Surge in Value - Knox Daily
Citi maintains Buy rating on American Tower stock with steady price target - Investing.com
Adobe price target lowered to $550 from $560 at UBS - TipRanks
TD Cowen Reiterates Buy Rating on Adobe (ADBE) - StreetInsider.com
Adobe stock slips on soft fourth-quarter revenue guidance - MSN
2,586 Shares in Analog Devices, Inc. (NASDAQ:ADI) Acquired by Ashton Thomas Private Wealth LLC - Defense World
Aditxt, Inc. Outlines Growth Strategies at Global Investment Conference - TipRanks
BioMedNewsBreaks — Aditxt Inc. (NASDAQ: ADTX) Enters into Second Amendment to Amended and Restated Merger Agreement with Evofem - Kalkine Media
Aditxt Says Will Provide $1.5 Mln Of Financing By Sept 30, Additional $1.5 Mln By Oct 31 - XM
Aditxt, Evofem enter second amendment to plan of merger - TipRanks
Aditxt and Evofem Sign Second Amendment to Amended and Restated Merger Agreement, Target Closing of Acquisition in Fourth Quarter of 2024 - Quantisnow
Aditxt Inc: Rising -98.90% from 52-Week Low, Can the Stock Stay Afloat? - The InvestChronicle
ADTX stock touches 52-week low at $0.54 amid market challenges - Investing.com
Aditxt subsidiary seeks $2M for prostate cancer test - Investing.com
Aditxt subsidiary seeks $2M for prostate cancer test - Investing.com India
ADTX stock touches 52-week low at $0.54 amid market challenges - Investing.com UK
Aditxt Subsidiary Pearsanta Submits a Grant Application Seeking to Advance Clinical Trials for Mitomic® Prostate Test, Targeting Early Detection in High-Risk Patients - StockTitan
Is Aditxt Inc (ADTX) worth investing in despite its overvalued state? - US Post News
Prepare Yourself for Liftoff: Aditxt Inc (ADTX) - SETE News
Ratio Examination: Aditxt Inc (ADTX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Aditxt to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 9th-11th, 2024 - Quantisnow
Aditxt extends senior note maturity to September 30 By Investing.com - Investing.com Australia
Aditxt extends senior note maturity to September 30 By Investing.com - Investing.com Canada
Aditxt extends senior note maturity to September 30 - Investing.com
Aditxt extends senior note maturity to September 30 By Investing.com - Investing.com UK
Aditxt Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - The InvestChronicle
Stock Market Recap: Aditxt Inc (ADTX) Concludes at 0.79, a -11.70 Surge/Decline - The Dwinnex
Pearsanta appoints Christopher Mitton as President By Investing.com - Investing.com Australia
Pearsanta appoints Christopher Mitton as President - Investing.com
Pearsanta appoints Christopher Mitton as President By Investing.com - Investing.com Canada
Pearsanta appoints Christopher Mitton as President - Investing.com India
ADTXAditxt, Inc. Latest Stock News & Market Updates - StockTitan
Aditxt's Precision Health Subsidiary, Pearsanta, Appoints Christopher Mitton as President as it Seeks to Complete Clinical Validation Studies for its Mitomic® Endometriosis Test (MET™) and Mitomic® Prostate Test (MPT™) - Quantisnow
Pearsanta appoints Christopher Mitton as President By Investing.com - Investing.com UK
Aditxt’s Precision Health Subsidiary, Pearsanta, Appoints Christopher Mitton as President as it Seeks to Complete Clinical Validation Studies for its Mitomic® Endometriosis Test (MET™) and Mitomic® Prostate Test (MPT™) - Elk Valley Times
Aditxt’s Precision Health Subsidiary, Pearsanta, Appoints Christopher Mitton as President as it Seeks to Complete Clinical Validation Studies for its Mitomic® Endometriosis Test (MET™) and Mitomic® Prostate Test (MPT™) - StockTitan
ADTX stock touches 52-week low at $0.88 amid market challenges - Investing.com Australia
500: Something went wrong - Investing.com India
ADTX stock touches 52-week low at $0.88 amid market challenges - Investing.com
ADTX stock touches 52-week low at $0.88 amid market challenges - Investing.com UK
Aditxt extends Appili acquisition deadline to November 19 - Investing.com
Evofem Biosciences amends merger agreement with Aditxt By Investing.com - Investing.com Australia
Aditxt extends Appili acquisition deadline to November 19 By Investing.com - Investing.com Australia
Aditxt extends Appili acquisition deadline to November 19 By Investing.com - Investing.com UK
ADTX’s Stock Dilemma: Aditxt Inc’s Market Performance and Outlook - The InvestChronicle
Aditxt Announces Third Amendment to Arrangement Agreement with Appili Therapeutics - Elk Valley Times
Aditxt Announces Third Amendment to Arrangement Agreement with Appili Therapeutics - Quantisnow
Appili Therapeutics Modifies Acquisition Deal with Aditxt - TipRanks
Market Update: Aditxt Inc (ADTX) Sees Negative Movement, Closing at 0.95 - The Dwinnex
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):